Liposomal doxorubicin supercharge‐containing front‐line treatment in patients with advanced‐stage diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single‐centre phase II study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liposomal doxorubicin supercharge‐containing front‐line treatment in patients with advanced‐stage diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single‐centre phase II study
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-07-13
DOI
10.1111/bjh.18348
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
- (2022) Richard T. Hoppe et al. Journal of the National Comprehensive Cancer Network
- Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis
- (2021) Carlo Visco et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
- (2021) Hervé Tilly et al. NEW ENGLAND JOURNAL OF MEDICINE
- International prognostic indices in diffuse large B-cell lymphoma (DLBCL): a comparison of IPI, R-IPI and NCCN-IPI
- (2020) Amy S Ruppert et al. BLOOD
- Drug Resistance in Non-Hodgkin Lymphomas
- (2020) Pavel Klener et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma
- (2020) M. Picardi et al. EUROPEAN JOURNAL OF CANCER
- Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis
- (2020) A. J. N. Raymakers et al. BMC CANCER
- The role of PET/CT in the modern treatment of Hodgkin lymphoma
- (2019) Jan Maciej Zaucha et al. CANCER TREATMENT REVIEWS
- Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)
- (2019) Flavia Salvi et al. LEUKEMIA & LYMPHOMA
- What Is the Cardiac Impact of Chemotherapy and Subsequent Radiotherapy in Lymphoma Patients?
- (2019) Valentina Mercurio et al. ANTIOXIDANTS & REDOX SIGNALING
- Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
- (2019) Alexandra Ioana Cioroianu et al. Analytical Cellular Pathology
- The interstitial macrophage: A long-neglected piece in the puzzle of lung immunity
- (2018) Maude Liegeois et al. CELLULAR IMMUNOLOGY
- Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations
- (2017) Ruijuan Luo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Interim Positron Emission Tomography Response–Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study
- (2016) Pier Luigi Zinzani et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma
- (2015) Alfonso Maria D'Arco et al. BRITISH JOURNAL OF HAEMATOLOGY
- Macrophages: Their Emerging Roles in Bone
- (2015) Benjamin P Sinder et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
- (2015) Miles A. Miller et al. Nature Communications
- The Role of Angiogenesis in Human Non-Hodgkin Lymphomas
- (2015) Domenico Ribatti et al. NEOPLASIA
- A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma
- (2014) Filippo Russo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity
- (2013) A Gibb et al. BRITISH JOURNAL OF CANCER
- International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era
- (2012) Alden A. Moccia et al. JOURNAL OF CLINICAL ONCOLOGY
- ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
- (2011) Simonetta Viviani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen
- (2010) M. Picardi et al. ANNALS OF ONCOLOGY
- Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
- (2010) Craig H. Moskowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
- (2009) R.C.F. Leonard et al. BREAST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started